Yakir Rottenberg1, Angela G E M de Boer2. 1. The Department of Oncology, Hadassah-Hebrew University Medical Center and Hebrew University-Hadassah Medical School, 91120, Jerusalem, Israel. ryakir@hadassah.org.il. 2. Coronel Institute of Occupational Health, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Abstract
PURPOSE: To clarify the association between cancer diagnosis and subsequent risk of being unemployed at 10 years after diagnosis among very long-term survivors. METHODS: A historical cohort study using prospectively collected data was done which included baseline measurements from the Israeli national census. Only patients who were 50 years old or younger at the time of diagnosis were included in the current study. Binary logistic regression analyses were used to assess odds ratios for unemployment at 10 years following diagnosis, while controlling for socioeconomic measurements and employment status at 2 years prior to diagnosis. RESULTS: The final study population included 2493 patients who were diagnosed with cancer and 7360 persons without a history of cancer, after excluding individuals who died before the end of 2015. After controlling for confounders, positive associations were found between cancer and increased risk for unemployment at 10 years (OR = 1.31, 95% CI 1.17-1.47). Analysis by cancer type revealed that patients who were diagnosed with CNS malignancies (OR = 2.71, 95% CI 1.80-4.07), followed by patients who were diagnosed with lymphoma (OR = 1.66, 95% CI 1.16-1.28) showed the greatest magnitude of effect, while the association between unemployment at 10 years following diagnosis and breast cancer was found to weaken and actually lose significance (adjusted OR = 1.22, 95% CI 0.99-1.50). CONCLUSIONS: Cancer survivors have an increased risk for long-term unemployment among very long-term survivors, mainly among patients diagnosed with CNS malignancies and lymphoma. IMPLICATIONS FOR CANCER SURVIVORS: The current study emphasizes the need for tailored intervention in order to mitigate the long-term risk of unemployment.
PURPOSE: To clarify the association between cancer diagnosis and subsequent risk of being unemployed at 10 years after diagnosis among very long-term survivors. METHODS: A historical cohort study using prospectively collected data was done which included baseline measurements from the Israeli national census. Only patients who were 50 years old or younger at the time of diagnosis were included in the current study. Binary logistic regression analyses were used to assess odds ratios for unemployment at 10 years following diagnosis, while controlling for socioeconomic measurements and employment status at 2 years prior to diagnosis. RESULTS: The final study population included 2493 patients who were diagnosed with cancer and 7360 persons without a history of cancer, after excluding individuals who died before the end of 2015. After controlling for confounders, positive associations were found between cancer and increased risk for unemployment at 10 years (OR = 1.31, 95% CI 1.17-1.47). Analysis by cancer type revealed that patients who were diagnosed with CNS malignancies (OR = 2.71, 95% CI 1.80-4.07), followed by patients who were diagnosed with lymphoma (OR = 1.66, 95% CI 1.16-1.28) showed the greatest magnitude of effect, while the association between unemployment at 10 years following diagnosis and breast cancer was found to weaken and actually lose significance (adjusted OR = 1.22, 95% CI 0.99-1.50). CONCLUSIONS:Cancer survivors have an increased risk for long-term unemployment among very long-term survivors, mainly among patients diagnosed with CNS malignancies and lymphoma. IMPLICATIONS FOR CANCER SURVIVORS: The current study emphasizes the need for tailored intervention in order to mitigate the long-term risk of unemployment.
Entities:
Keywords:
Unemployment; a population based study; cohort study
Authors: Sara Gandini; Francesco Sera; Maria Sofia Cattaruzza; Paolo Pasquini; Orietta Picconi; Peter Boyle; Carmelo Francesco Melchi Journal: Eur J Cancer Date: 2005-01 Impact factor: 9.162
Authors: Christina K Cramer; Neil McKee; L Doug Case; Michael D Chan; Tiffany L Cummings; Glenn J Lesser; Edward G Shaw; Stephen R Rapp Journal: J Neurooncol Date: 2018-11-07 Impact factor: 4.130
Authors: I Glimelius; S Ekberg; J Linderoth; M Jerkeman; E T Chang; M Neovius; K E Smedby Journal: J Cancer Surviv Date: 2015-02-18 Impact factor: 4.442
Authors: Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans Journal: Lancet Neurol Date: 2009-08-07 Impact factor: 44.182
Authors: M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn Journal: Lancet Date: 2002-11-02 Impact factor: 79.321
Authors: Angela G E M de Boer; Taina Taskila; Anneli Ojajärvi; Frank J H van Dijk; Jos H A M Verbeek Journal: JAMA Date: 2009-02-18 Impact factor: 56.272
Authors: Anne-Claire G N M Zaman; Kristien M A J Tytgat; Sanne van Hezel; Jean H G Klinkenbijl; Angela G E M de Boer; Monique H W Frings-Dresen Journal: Eur J Cancer Care (Engl) Date: 2017-10-12 Impact factor: 2.520